CVS HEALTH (CVS) DIvidends Date & History

Key Takeaways

• CVS Health pays a quarterly dividend of $0.665 per share, equating to an annual payout of $2.66 and a current yield of approximately 2.55%.
• The dividend has grown at an average annual rate of about 6.6% over the past decade, though recent increases have paused.
• Earnings payout ratio exceeds 115%, but free cash flow coverage remains strong at roughly 46%.
• CVS Health has maintained consistent quarterly payments with no cuts in its history, supporting long-term reliability.
• The yield exceeds the healthcare sector average, appealing to income-focused investors seeking stability.
• Future dividend growth depends on earnings recovery and cash flow generation amid sector challenges.

Dividend Overview

CVS Health Corporation (CVS) follows a quarterly dividend policy, distributing payments in February, May, August, and November. The current annualized dividend stands at $2.66 per share, resulting in a forward yield near 2.55%. This positions CVS Health as a modest-yield dividend stock rather than a high-yield play, with emphasis on consistent payments and gradual growth. The company has prioritized dividend stability within the healthcare sector, where it operates pharmacies, retail clinics, and insurance services through Aetna.

Dividend History and Growth

CVS Health has raised its dividend at an average annual rate of 6.6% over the past 10 years. The quarterly rate reached $0.665 and has remained unchanged for multiple periods, reflecting a pause in increases amid operational adjustments. Despite this, the company has delivered consistent payments without reductions, maintaining a track record of reliability. Long-term strategy focuses on balancing shareholder returns with investments in core operations and debt management.

Dividend Sustainability and Payout Ratio

The earnings payout ratio near 115% appears elevated, suggesting the dividend exceeds current net income. However, coverage improves significantly when measured against free cash flow, with ratios around 46%. Strong operating cash flow generation supports ongoing payments, and management has provided positive guidance for future cash flows. Debt levels and sector-specific pressures, such as pharmacy benefit management regulations, warrant monitoring, but overall financial stability indicates the dividend remains sustainable in the near term.

Dividend Compared to Industry Peers

CVS Health's yield of approximately 2.55% exceeds the healthcare sector average of about 1.6%. Peers in retail pharmacy and managed care often offer lower yields with varying growth profiles. This relative premium reflects CVS Health's mature business model and cash generation capabilities, though it trails some higher-yielding names in broader consumer sectors. The profile suits investors seeking balanced exposure within healthcare rather than maximum income.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore opportunities with the AI Screener.

Is This Stock Attractive for Dividend Investors?

CVS Health may appeal to income investors seeking a moderate yield backed by substantial free cash flow within the healthcare industry. Dividend growth investors could view the recent pause as temporary, given the company's long-term increase history and expected earnings expansion. Conservative, long-term holders might value the absence of cuts and quarterly consistency, though elevated earnings payout ratios suggest monitoring for sustainability. The stock suits those prioritizing sector stability over aggressive yield or rapid growth, with potential benefits from healthcare demand trends. Investors should assess personal risk tolerance and broader portfolio needs.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.